Evaluating the Impact of COVID-19 on the Adoption of Virtual Care in General Practice in 20 Countries (inSIGHT): Protocol and Rationale Study.

digital-first models patient safety primary care quality of care telemedicine virtual care

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
26 Aug 2021
Historique:
received: 02 05 2021
accepted: 19 07 2021
revised: 29 06 2021
pubmed: 23 7 2021
medline: 23 7 2021
entrez: 22 7 2021
Statut: epublish

Résumé

In recent decades, virtual care has emerged as a promising option to support primary care delivery. However, despite the potential, adoption rates remained low. With the outbreak of COVID-19, it has suddenly been pushed to the forefront of care delivery. As we progress into the second year of the COVID-19 pandemic, there is a need and opportunity to review the impact remote care had in primary care settings and reassess its potential future role. This study aims to explore the perspectives of general practitioners (GPs) and family doctors on the (1) use of virtual care during the COVID-19 pandemic, (2) perceived impact on quality and safety of care, and (3) essential factors for high-quality and sustainable use of virtual care in the future. This study used an online cross-sectional questionnaire completed by GPs distributed across 20 countries. The survey was hosted in Qualtrics and distributed using email, social media, and the researchers' personal contact networks. GPs were eligible for the survey if they were working mainly in primary care during the period of the COVID-19 pandemic. Descriptive statistical analysis will be performed for quantitative variables, and relationships between the use of virtual care and perceptions on impact on quality and safety of care and participants' characteristics may be explored. Qualitative data (free-text responses) will be analyzed using framework analysis. Data collection took place from June 2020 to September 2020. As of this manuscript's submission, a total of 1605 GP respondents participated in the questionnaire. Further data analysis is currently ongoing. The study will provide a comprehensive overview of the availability of virtual care technologies, perceived impact on quality and safety of care, and essential factors for high-quality future use. In addition, a description of the underlying factors that influence this adoption and perceptions, in both individual GP and family doctor characteristics and the context in which they work, will be provided. While the COVID-19 pandemic may prove the first great stress test of the capabilities, capacity, and robustness of digital systems currently in use, remote care will likely remain an increasingly common approach in the future. There is an imperative to identify the main lessons from this unexpected transformation and use them to inform policy decisions and health service design. DERR1-10.2196/30099.

Sections du résumé

BACKGROUND BACKGROUND
In recent decades, virtual care has emerged as a promising option to support primary care delivery. However, despite the potential, adoption rates remained low. With the outbreak of COVID-19, it has suddenly been pushed to the forefront of care delivery. As we progress into the second year of the COVID-19 pandemic, there is a need and opportunity to review the impact remote care had in primary care settings and reassess its potential future role.
OBJECTIVE OBJECTIVE
This study aims to explore the perspectives of general practitioners (GPs) and family doctors on the (1) use of virtual care during the COVID-19 pandemic, (2) perceived impact on quality and safety of care, and (3) essential factors for high-quality and sustainable use of virtual care in the future.
METHODS METHODS
This study used an online cross-sectional questionnaire completed by GPs distributed across 20 countries. The survey was hosted in Qualtrics and distributed using email, social media, and the researchers' personal contact networks. GPs were eligible for the survey if they were working mainly in primary care during the period of the COVID-19 pandemic. Descriptive statistical analysis will be performed for quantitative variables, and relationships between the use of virtual care and perceptions on impact on quality and safety of care and participants' characteristics may be explored. Qualitative data (free-text responses) will be analyzed using framework analysis.
RESULTS RESULTS
Data collection took place from June 2020 to September 2020. As of this manuscript's submission, a total of 1605 GP respondents participated in the questionnaire. Further data analysis is currently ongoing.
CONCLUSIONS CONCLUSIONS
The study will provide a comprehensive overview of the availability of virtual care technologies, perceived impact on quality and safety of care, and essential factors for high-quality future use. In addition, a description of the underlying factors that influence this adoption and perceptions, in both individual GP and family doctor characteristics and the context in which they work, will be provided. While the COVID-19 pandemic may prove the first great stress test of the capabilities, capacity, and robustness of digital systems currently in use, remote care will likely remain an increasingly common approach in the future. There is an imperative to identify the main lessons from this unexpected transformation and use them to inform policy decisions and health service design.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
DERR1-10.2196/30099.

Identifiants

pubmed: 34292867
pii: v10i8e30099
doi: 10.2196/30099
pmc: PMC8396553
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e30099

Informations de copyright

©Ana Luísa Neves, Edmond Li, Alice Serafini, Geronimo Jimenez, Heidrun Lingner, Tuomas H Koskela, Robert D Hoffman, Claire Collins, Davorina Petek, Ana Claveria, Rosy Tsopra, Greg Irving, Gustavo Gusso, Braden Gregory O’Neill, Kyle Hoedebecke, Sandra Milena Espitia, Mehmet Ungan, Katarzyna Nessler, Vanja Lazic, Liliana Laranjo, Ensieh Memarian, Maria Jose Fernandez, Saira Ghafur, Gianluca Fontana, Azeem Majeed, Josip Car, Ara Darzi. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 26.08.2021.

Références

JAMA Netw Open. 2020 Oct 1;3(10):e2021476
pubmed: 33006622
J Med Internet Res. 2019 Apr 08;21(4):e11604
pubmed: 30958272
J Med Internet Res. 2008 Oct 16;10(4):e30
pubmed: 18926979
Health Promot Perspect. 2011 Dec 20;1(2):86-94
pubmed: 24688904
J Med Internet Res. 2016 Apr 14;18(4):e75
pubmed: 27080852
JAMA Intern Med. 2019 Apr 1;179(4):506-514
pubmed: 30776056
Telemed J E Health. 2019 Feb;25(2):132-136
pubmed: 29847224
BMJ. 2020 Oct 20;371:m3945
pubmed: 33082127
Health Aff (Millwood). 2014 Feb;33(2):251-7
pubmed: 24493768
Front Public Health. 2021 Feb 03;9:623904
pubmed: 33614587
BMC Med Res Methodol. 2014 Jun 06;14:76
pubmed: 24906492
Telemed J E Health. 2020 May;26(5):571-573
pubmed: 32275485
BMC Fam Pract. 2021 Feb 20;22(1):40
pubmed: 33610171
Aust Fam Physician. 2011 Jun;40(6):427-30
pubmed: 21655493
Nat Med. 2020 Apr;26(4):459-461
pubmed: 32284618
Ann Intern Med. 2007 Oct 16;147(8):573-7
pubmed: 17938396
BMJ. 2018 Mar 29;360:k1047
pubmed: 29599197
Isr J Health Policy Res. 2020 Oct 20;9(1):53
pubmed: 33081834
BMJ Open Qual. 2021 Mar;10(1):
pubmed: 33781992
Br J Gen Pract. 2021 Feb 25;71(704):e166-e177
pubmed: 33558332
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937

Auteurs

Ana Luísa Neves (AL)

Institute of Global Health Innovation, Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.

Edmond Li (E)

Institute of Global Health Innovation, Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.

Alice Serafini (A)

Local Health Authority of Modena, Modena, Italy.

Geronimo Jimenez (G)

Center for Population Health Sciences, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.

Heidrun Lingner (H)

Center for Public Health and Healthcare, German Center for Lung Research (DZL) / BREATH Hannover, Hannover Medical School, Hannover, Germany.

Tuomas H Koskela (TH)

Department of General Practice, Faculty of Medicine and Health Technology, Tampere University Hospital, Tampere University, Tampere, Finland.

Robert D Hoffman (RD)

Department of Family Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Claire Collins (C)

Irish College of General Practitioners, Dublin, Ireland.

Davorina Petek (D)

Department of Family Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Ana Claveria (A)

Primary Care Research Unit, Vigo Health Area, Vigo, Spain.
Galicia South Health Research Institute, Vigo, Spain.

Rosy Tsopra (R)

Information Sciences to Support Personalized Medicine, Centre de Recherche des Cordeliers, Sorbonne Université, INSERM, Université de Paris, Paris, France.
Department of Medical Informatics, Hôpital Européen Georges-Pompidou, Assistance Publique - Hôpitaux de Paris, Paris, France.

Greg Irving (G)

Health Research Institute, Edge Hill University, Ormskirk, United Kingdom.

Gustavo Gusso (G)

Department of Internal Medicine, Universidade de Sao Paulo, Sao Paulo, Brazil.

Braden Gregory O'Neill (BG)

MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada.

Kyle Hoedebecke (K)

Department of Utilization Management, Oscar Health, Dallas, TX, United States.

Sandra Milena Espitia (SM)

Colombian Society of Family Medicine, Bogotá, Colombia.

Mehmet Ungan (M)

Department of Family Medicine, Ankara University School of Medicine, Ankara, Turkey.

Katarzyna Nessler (K)

Department of Family Medicine, Jagiellonian University Medical College, Krakow, Poland.

Vanja Lazic (V)

Health Center Zagreb, Zagreb, Croatia.

Liliana Laranjo (L)

Westmead Applied Research Centre, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Australian Institute of Health Innovation, Macquarie University, Sydney, Australia.

Ensieh Memarian (E)

Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.
Internal Medicine and Epidemiology Research Group, Skane University Hospital, Malmö, Sweden.

Maria Jose Fernandez (MJ)

Galicia South Health Research Institute, Vigo, Spain.
Leiro Health Center, Leiro, Spain.

Saira Ghafur (S)

Institute of Global Health Innovation, Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.

Gianluca Fontana (G)

Institute of Global Health Innovation, Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.

Azeem Majeed (A)

Department of Primary Care & Public Health, School of Public Health, Imperial College London, London, United Kingdom.

Josip Car (J)

Center for Population Health Sciences, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Department of Primary Care & Public Health, School of Public Health, Imperial College London, London, United Kingdom.

Ara Darzi (A)

Institute of Global Health Innovation, Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.

Classifications MeSH